Clin2
NCT03514589Possibly a fitRecruiting

Testing a noninvasive Synacthen test in kids and healthy adults

Adrenal Suppression

Part of Hormones & metabolism clinical trials.

This trial studies how well a short, noninvasive Synacthen test works in people at different ages, including children with asthma. It’s meant to safely measure how the body responds to a hormone signal without needing more invasive testing.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
12 people
Ages
6 months to 60 years
Study type
Interventional

Who can take part

  • You (or your child) are in the right age group for one study group: adult (18–64) or child (0–18, or 2–15 depending on group)
  • You are generally healthy if you’re in the “healthy” groups, or you have asthma if you’re in the asthma group
  • You are not using any medications at the time of the test (or weren’t recently using corticosteroids)
  • No history of hormone gland problems, and no history of serious adrenal, kidney, or brain-related hormone problems
  • No past allergic reaction to ACTH or Synacthen, and no history of severe allergic reactions
  • No recent cold/nose symptoms in the last week, and you are not a current smoker

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05149638Recruiting
Checking updated cortisol lab values for adrenal insufficiency

This study tests whether updated cortisol test numbers better identify adrenal insufficiency, a hormone condition where your body doesn’t make enough stress hormone. It may help doctors confirm the diagnosis and choose safer next steps for treatment.

The Bronx, New York
NCT06079788Recruiting· Phase 3
ACTH for children with frequently relapsing nephrotic syndrome

This trial tests if a hormone called ACTH can help children with nephrotic syndrome who have frequent relapses or need steroids to stay in remission. It aims to find a treatment that may reduce the need for steroids and prevent relapses.

Wuhan, Hubei
NCT07665892Recruiting· Phase 1
Testing a new asthma drug in adults

This study tests a new medication called ASY202 for adults with stable asthma. The goal is to see if it's safe and how the body processes it. It may be an option for those who have not had a recent asthma attack or infection.

Glendale, Arizona
NCT07352527Recruiting
New blood test for adrenal nodule diagnosis

This trial is testing a new method (using a blood test that measures steroid hormones) to better diagnose whether adrenal nodules are causing mild hormone problems. It may help doctors decide if you need treatment or just monitoring.

Pessac
NCT07038746Recruiting· Phase 1
Inhaled epinephrine for severe allergic reactions during tests or treatment

This trial tests if inhaled epinephrine can safely treat moderate to severe allergic reactions (grade 2 or higher) that can happen during allergy skin tests, oral food or drug challenges, or allergy shots. It is for people who have had such reactions in the past or are at risk and are planning to undergo one of these procedures.

Richmond, British Columbia
NCT07703098Not yet recruiting· Phase 4
Comparing two steroids for adrenal insufficiency after long-term steroid use

This trial compares two steroid medicines (hydrocortisone and methylprednisolone) to see which one works better for people whose adrenal glands have stopped working properly after taking high doses of steroids for a long time. It aims to find the safest and most effective way to replace the missing hormones.

Ljubljana

Hear when a new Adrenal Suppression trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.